论著

绝经后2型糖尿病女性性激素水平与体质指数的关系

Relationship between sex hormone levels and body mass index in postmenopausal women with type 2 diabetes mellitus

:39-43
 
目的 探讨绝经后2型糖尿病人群性激素水平与体质指数(BMI)的关系。方法 收集2022年1月—2023年1月在我院住院的2型糖尿病患者,随机选取自然绝经后女性184例,根据其BMI分组,其中肥胖组23例、超重组74例、BMI正常组87例,比较3组间临床资料及性激素差异。结果 3组间腰围、空腹血糖(FPG)、甘油三酯、高密度脂蛋白胆固醇、血尿酸、卵泡刺激素(FSH)、黄体生成素(LH)、雌激素(E2)比较差异均有统计学意义(均P<0.05),肥胖组和超重组的E2高于正常组,FSH及LH低于正常组。3组间年龄、糖化血红蛋白、收缩压、舒张压、总胆固醇、低密度脂蛋白胆固醇、催乳素、睾酮、孕酮比较差异均无统计学意义(均P>0.05)。Logistic回归分析显示,过高的腰围和较低的FSH、LH是绝经后2型糖尿病女性肥胖的影响因素。结论 2型糖尿病绝经后女性应控制腹型肥胖,定期复查LH、FSH,提早干预。
Objective To investigate the relationship between sex hormone levels and body mass index(BMI)in postmenopausal women with type 2 diabetes mellitus(T2DM).Methods A total of 184 cases of natural postmenopausal women with T2DM admitted to our hospital from January 2022 to January 2023 were randomly selected,including 23 cases of obesity,74 cases of over weight and 87 cases of normal BMI.The clinical data and sex hormones among the three groups were analyzed.Results Waist circumference,fasting plasma glucose(FPG),triglyceride,high density lipoprotein cholesterol,uric acid,follicle-stimulating hormone(FSH),luteinizing hormone(LH)and oestrogen(E2)levels were significantly different among the three groups(P<0.05).E2 levels of the obesity group and the over weight group were significantly higher than that of the normal group,while FSH and LH levels were significantly lower than that of the normal group.There was no significant difference in age,hemoglobin A1c,systolic blood pressure,diastolic blood pressure,total cholesterol,low density lipoprotein cholesterol,prolactin,testosterone and progesterone levels among the three groups(P>0.05).Logistic regression analysis showed that higher waist circumference and lower FSH and LH levels were significantly correlated with obesity in postmenopausal women with T2DM.Conclusions Abdominal obesity should be controlled in postmenopausal women with T2DM,and LH and FSH should be periodically reviewed,in order to treat in advance.
出版者信息








《广州医药》公众号